EORTC OV28
Research type
Research Study
Full title
Update of the Quality of Life Questionnaire for Ovarian Cancer Patients
IRAS ID
350580
Contact name
Andrew Nordin
Contact email
Sponsor organisation
East Kent Hospitals University NHS Foundation Trust
Duration of Study in the UK
0 years, 4 months, 1 days
Research summary
The European Organisation of Research and Treatment of Cancer’s Quality of Life Group (EORTC QLG) has developed a four-phase framework that can be used to develop and validate quality of life questionnaires for individuals with cancer. These are developed as modules to supplement their existing EORTC core quality of life questionnaire, the ‘QLQ-C30’. For example, modules have previously been developed for endometrial cancer (QLQEN24), bone metastases (QLQ-BM22), and cancer-related fatigue (QLQ-FA12). The four-phase approach comprises a literature review followed by interviews with patients and clinicians (Phase 1), construction of a questionnaire (Phase 2), refinement of the questionnaire (Phase 3), and finally administration of the questionnaire to an international sample in a full validation study (Phase 4).
The present study aims to contribute to the development of a module designed to measure ovarian cancer. The study aims to undertake Phase 1 of the above module development process- for the update of the Quality of Life Questionnaire for ovarian cancer patients.REC name
London - Camden & Kings Cross Research Ethics Committee
REC reference
25/LO/0071
Date of REC Opinion
19 Feb 2025
REC opinion
Favourable Opinion